Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter
Titel:
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter
Auteur:
Pato Pato, A. Costa Arpín, E. Rodríguez Regal, A. Rodríguez Constenla, I. Cimas Hernando, I. Muñoz Pousa, I. Naya Ríos, L. Lorenzo González, J.R. Amigo Jorrín, M.C. Prieto González, J.M.